About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT01989039

IR, Inflammatory and Cardiovascular Markers in PCOS Among Obese and Non-obese Women

FPCOS is associated with an adverse cardiometabolic profile, consisting of increased total or central adiposity, increased insulin resistance and abnormal glucose metabolism. Low-grade chronic inflamm...

Lead sponsor: Taipei Medical University WanFang Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Ming I Hsu, MD

CONTACT

886-2-2930-7930 [email protected]

Sponsors

Lead Sponsor

Taipei Medical University WanFang Hospital

Age

13 - 48 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Women had been fulfilled with whole anthropometric measurements, clinic and biochemical survey about insulin resistance, cardiovascular and inflammatory markers.

Exclusion Criteria

•women who had been diagnosed with malignant tumor, Asherman's syndrome, Mullerian agenesis, ovarian failure, hyperprolactinemia, and chromosomal anomalies;
•women who had had menarche less than 1 years before evaluation or who were older than 49;
•women who received hormones or drugs for major medical diseases within three months.

Related studies

RECRUITINGPhase 2

Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT)

NCT07286747 · Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)

Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers

NCT07440147 · Obesity & Overweight, Circadian Rhythm Disorders, and more

Active Not RecruitingNA

Pharmacists' Delivery of Education to Prevent Diabetes in the New Orleans Hospitality Industry

NCT07451314 · Prediabetes, Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), and more

Active Not RecruitingNA

Resistance Training for the Improvement of Glycemic Control in Prediabetes

NCT06697756 · Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)

Active Not RecruitingNA

Topical Insulin for Postoperative Wound Healing

NCT06400082 · Wound Complication, Insulin Resistance, Diabetes

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 20, 2013Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment800

Start dateAug 2013

Last updatedNov 20, 2013

Condition

Polycystic Ovary Syndrome,Insulin Resistance,

Locations shown

WanFang Medical Center at Taipei Medical University

Taipei, Taiwan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 20, 2013Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions